| DC Field | Value | Language |
|---|
| dc.contributor.author | Rada, F. | - |
| dc.date.accessioned | 2025-11-17T11:32:14Z | - |
| dc.date.available | 2025-11-17T11:32:14Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.citation | Rada, F. Role of visfatin, sirtuin 1 and apelin in patients with autism disorder / F. Rada // Research Results in Pharmacology. - 2025. - Vol.11, №3.-P. 44-51. - Doi: 10.18413/rrpharmacology.11.578. - Refer.: p. 50-51. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/65892 | - |
| dc.description.abstract | The aim of the study was to quantify the serum levels of some nitrogen metabolites, sirtuin 1, visfatin, apelin and tumor necrosis factor-alpha in autistic patients and to evaluate their levels in contrast to normal participants | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | autism | ru |
| dc.subject | apelin | ru |
| dc.subject | cytokines | ru |
| dc.subject | glutamate dehydrogenase | ru |
| dc.subject | nitrogen metabolites | ru |
| dc.subject | sirtuin 1 | ru |
| dc.subject | visfatin | ru |
| dc.title | Role of visfatin, sirtuin 1 and apelin in patients with autism disorder | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 11, № 3
|
